Literature DB >> 11446485

Breast cancer in ectopic breast tissue.

C Markopoulos1, E Kouskos, K Kontzoglou, G Gogas, V Kyriakou, J Gogas.   

Abstract

Ectopic breasts usually develop along the mammary ridges. Their incidence has been reported as up to 5-6%. Development of malignancy is rare. We report three cases of postmenopausal female patients with breast cancer which developed in the axillary accessory breast. They were all successfully treated by surgery and adjuvant therapy. A review of the literature on the incidence and pathology of ectopic mammary tissue is also presented.

Entities:  

Mesh:

Year:  2001        PMID: 11446485

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Ectopic Male Breast Cancer in the Perineum: A Case Report.

Authors:  Hye-Joung Eom; Beom Seok Ko; In Hye Song; Gyungyub Gong; Hak Hee Kim
Journal:  J Breast Cancer       Date:  2017-12-19       Impact factor: 3.588

2.  Male accessory breast cancer successfully treated with endocrine therapy: A case report.

Authors:  Lintao Bi; Jun Li; Zhangzhen Shi; Zhenxing Zhu; Zhenxia Lu
Journal:  Oncol Lett       Date:  2015-08-12       Impact factor: 2.967

3.  Diagnosis and treatment of accessory breast cancer in 11 patients.

Authors:  Shuo Zhang; Yong-Hua Yu; Wei Qu; Yong Zhang; Jia Li
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

4.  Accessory Breast Carcinoma.

Authors:  Hyun Jo Youn; Sung Hoo Jung
Journal:  Breast Care (Basel)       Date:  2009-04-24       Impact factor: 2.860

5.  Accessory breast tissue mimicking pedunculated lipoma.

Authors:  Musharraf Husain; Sabina Khan; Ashraf Bhat; Firdoos Hajini
Journal:  BMJ Case Rep       Date:  2014-07-08

Review 6.  Axillary masses as clinical manifestations of male sweat gland carcinoma associated with extramammary Paget's disease and accessory breast carcinoma: two cases report and literature review.

Authors:  Jing Wu; Hongdan Chen; Fan Zhang; Xiaohua Zeng; Juanhui Dong; Yong Cao; Wei Li
Journal:  World J Surg Oncol       Date:  2022-04-04       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.